
PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial Hypertension
Pulmonary HypertensionThe purpose of this study is to evaluate the safety and effectiveness of tadalafil for the treatment of pulmonary arterial hypertension.

Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Comparing Telmisartan vs Valsartan....
HypertensionThe primary objective of this study is to compare the effectiveness of telmisartan 80 mg / hydrochlorothiazide 25 mg [Micardis HCT] to valsartan 160 mg / hydrochlorothiazide 25 mg [Diovan HCT] and placebo in the treatment of Stage 1 and Stage 2 hypertension.

Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular...
Open-angle GlaucomaOcular HypertensionThe purpose of this study is to determine the safety and IOP-lowering ability of a glaucoma therapy in patients with open-angle glaucoma or ocular hypertension.

Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension
Pulmonary HypertensionOBJECTIVES: I. Determine the safety and efficacy of UT-15 in patients with severe symptomatic primary pulmonary hypertension.

Treatment of Hypertension With Two Exercise Intensities
HypertensionTo determine whether exercise training could significantly replace medication as a treatment for mild essential hypertension.

Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And...
HypertensionEvaluation of the effect of two different antihypertensive treatments on control of glucose in Type II diabetic patients with high blood pressure

Potential Risk Factors for Stroke
Carotid AtherosclerosisCerebrovascular Accident3 moreEarly studies have shown that the immune system may play a role in the development of strokes. Conditions such as high blood pressure, high cholesterol, diabetes, and old age can activate the immune system and increase the risk of developing hardening of the arteries (atherosclerosis) and damaged blood vessels. Researchers will attempt to characterize factors that may contribute to atherosclerosis and stroke by measuring certain components of the immune system, cytokines and leukocyte activation. Measurements will be taken from patients that are considered to be stroke prone and from patients without risk factors for the development of stroke. Researchers will measure the immune system components at the beginning of the study, at six months, and at the one-year completion of the study. The study will attempt to determine; I) If patients with risk factors for stroke have an increased activation of the immune system II) If patients with risk factors for stroke that are symptomatic have higher levels of immune system activation compared to patients who do not have symptoms III) If patients with increased activation of the immune system have accelerated hardening of the arteries (atherosclerosis)

Dietary Approaches to Stop Hypertension (DASH)
Cardiovascular DiseasesHeart Diseases2 moreTo test the effectiveness of dietary patterns in lowering blood pressure.

Systolic Hypertension in the Elderly Program (SHEP) (Pilot Study)
Cardiovascular DiseasesHeart Diseases2 moreThe SHEP Pilot Study had six objectives, each designed to develop and test critical components of a full scale trial directed at the health consequences of treating isolated systolic hypertension (ISH) in the elderly. l. To estimate and compare the yield of participants for randomization into a clinical trial from various community groups using various recruitment techniques. 2. To estimate compliance with the visit schedule and to the prescribed double-blind regimens. 3. To estimate and compare the effectiveness of specified antihypertensive medications in reducing the blood pressure. 4. To estimate and compare the unwanted effects of specified antihypertensive medication in an elderly population. 5. To evaluate the feasibility and effectiveness of periodic behavioral assessment in this population. 6. To develop and test methods of ascertaining stroke and other disease endpoints.

Polyunsaturates and KCL to Control Mild Hypertension
Cardiovascular DiseasesHeart Diseases2 moreTo test the efficacy of omega-3 fatty acids in untreated mild hypertensives and magnesium, calcium, and potassium supplementation supplementation in non-hypertensives. These clinical trials were conducted in sequence over a four year period.